Evidence map›Paper›PMID 41747186›Full record

ArticleBlood advances2026

Intensity of conditioning but not measurable residual disease status affects the outcomes of umbilical cord blood transplantation.

Luke Ka Lok Chan, Emma Nicholson, Li Yuan Chan, David Taussig, Mike Potter, Mark Ethell, Sandra Easdale, Catherine Garnett, Chloe Anthias

Abstract read
In one paragraph

Article in Blood advances, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Luke Ka Lok ChanHaemato-oncology Unit, The Royal Marsden NHS Foundation Trust, London, United Kingdom.ORCID 0000-0002-3441-264X
Emma NicholsonHaemato-oncology Unit, The Royal Marsden NHS Foundation Trust, London, United Kingdom.ORCID 0000-0002-6439-0795
Li Yuan ChanHaemato-oncology Unit, The Royal Marsden NHS Foundation Trust, London, United Kingdom.ORCID 0000-0003-3737-0905
David TaussigHaemato-oncology Unit, The Royal Marsden NHS Foundation Trust, London, United Kingdom.ORCID 0000-0002-9621-0146
Mike PotterHaemato-oncology Unit, The Royal Marsden NHS Foundation Trust, London, United Kingdom.
Mark EthellHaemato-oncology Unit, The Royal Marsden NHS Foundation Trust, London, United Kingdom.
Sandra EasdaleHaemato-oncology Unit, The Royal Marsden NHS Foundation Trust, London, United Kingdom.ORCID 0000-0001-6118-0138
Catherine GarnettHaemato-oncology Unit, The Royal Marsden NHS Foundation Trust, London, United Kingdom.
Chloe AnthiasHaemato-oncology Unit, The Royal Marsden NHS Foundation Trust, London, United Kingdom.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID41747186
PMCPMC13146541

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.